KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Total Liabilities (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Total Liabilities for 13 consecutive years, with $69.7 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 405.27% to $69.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.7 million through Dec 2025, up 405.27% year-over-year, with the annual reading at $69.7 million for FY2025, 405.27% up from the prior year.
  • Total Liabilities hit $69.7 million in Q4 2025 for ClearPoint Neuro, up from $44.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $69.7 million in Q4 2025 to a low of $10.1 million in Q1 2025.
  • Historically, Total Liabilities has averaged $23.8 million across 5 years, with a median of $19.4 million in 2023.
  • Biggest YoY gain for Total Liabilities was 405.27% in 2025; the steepest drop was 47.08% in 2025.
  • Year by year, Total Liabilities stood at $16.8 million in 2021, then grew by 10.77% to $18.6 million in 2022, then grew by 15.51% to $21.5 million in 2023, then plummeted by 35.78% to $13.8 million in 2024, then surged by 405.27% to $69.7 million in 2025.
  • Business Quant data shows Total Liabilities for CLPT at $69.7 million in Q4 2025, $44.5 million in Q3 2025, and $43.1 million in Q2 2025.